Woodline Partners’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,089,594
| Closed | -$6.81M | – | 788 |
|
|
2023
Q1 | $6.81M | Buy |
1,089,594
+902,196
| +481% | +$5.64M | 0.09% | 248 |
|
|
2022
Q4 | $1.14M | Sell |
187,398
-337,271
| -64% | -$2.06M | 0.02% | 532 |
|
|
2022
Q3 | $6.27M | Buy |
524,669
+264,393
| +102% | +$3.16M | 0.09% | 257 |
|
|
2022
Q2 | $3.28M | Hold |
260,276
| – | – | 0.05% | 321 |
|
|
2022
Q1 | $2.93M | Hold |
260,276
| – | – | 0.05% | 320 |
|
|
2021
Q4 | $4.61M | Hold |
260,276
| – | – | 0.07% | 291 |
|
|
2021
Q3 | $5.99M | Hold |
260,276
| – | – | 0.1% | 227 |
|
|
2021
Q2 | $6.06M | Sell |
260,276
-25,853
| -9% | -$602K | 0.11% | 200 |
|
|
2021
Q1 | $8.92M | Buy |
286,129
+9,678
| +4% | +$302K | 0.2% | 131 |
|
|
2020
Q4 | $11M | Buy |
+276,451
| New | +$11M | 0.29% | 104 |
|